LEADER 01182nam a2200301 i 4500 001 991001246449707536 008 051006s2004 xxua b 000 0 eng d 020 $a0471230650 035 $ab13342678-39ule_inst 040 $aSet. Economia$bita 082 0 $a330.0151955 100 1 $aEnders, Walter$d<1948- >$0506897 245 10$aApplied econometric time series /$cWalter Enders 250 $a2. ed 260 $aNew York :$bWiley,$cc2004 300 $axiv, 460 p. :$bill. ;$c24 cm 440 0$aWiley series in probability and mathematical statistics 504 $aInclude riferimenti bibliografici e indice 650 $aSerie storiche$xModelli econometrici 650 4$aSerie temporali 650 4$aEconometria 907 $a.b13342678$b01-02-16$c06-10-05 912 $a991001246449707536 945 $aLE025 ECO 330 END01.01$g1$i2025000131040$lle025$op$pE17.00$q-$rl$s- $t0$u8$v4$w8$x0$y.i14202736$z08-03-06 945 $aLE027 330.01 END01.01$g1$i2027000124046$lle027$op$pE116.20$q-$rl$s- $t0$u1$v0$w1$x0$y.i14294588$z02-10-06 996 $aApplied econometric time series$934868 997 $aUNISALENTO 998 $ale025$ale027$b06-10-05$cm$da $e-$feng$gxxu$h0$i0 LEADER 02940nam 22005775 450 001 9910484969603321 005 20251113173622.0 010 $a3-030-57369-9 024 7 $a10.1007/978-3-030-57369-0 035 $a(CKB)4100000011665211 035 $a(DE-He213)978-3-030-57369-0 035 $a(MiAaPQ)EBC6427443 035 $a(PPN)252518705 035 $a(MiAaPQ)EBC29095468 035 $a(EXLCZ)994100000011665211 100 $a20201217d2021 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aCannabinoids and Neuropsychiatric Disorders /$fedited by Eric Murillo-Rodriguez, S. R. Pandi-Perumal, Jaime M. Monti 205 $a1st ed. 2021. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2021. 215 $a1 online resource (XVII, 153 p. 43 illus., 4 illus. in color.) 225 1 $aAdvances in Experimental Medicine and Biology,$x2214-8019 ;$v1264 311 08$a3-030-57371-0 311 08$a3-030-57368-0 330 $aThis volume highlights the recent advances in the understanding of the endocannabinoid system and the likely benefit from the therapeutic effects of cannabinoid treatment in a variety of health issues. Archeological evidence has shown that Cannabis has a long history of use for multiple purposes, including the treatment of medical conditions. The primary active constituent of the hemp plant Cannabis sativa, delta 9-tetrahydrocannabinol (?9-THC), causes euphoria, enhancement of sensory perception, tachycardia, antinociception, difficulties in concentration and impairment of memory, among other effects. Despite these undesirable effects, signaling is mostly inhibitory and suggests a putative role for cannabinoids as therapeutic agents by managing several diseases where inhibition of neurotransmitter release would be beneficial. The themes of this book have been edited and written by world-leaders in the field, The contents of the volume aims at readers from a range of academic and professional disciplines, such as biomedicine, several areas of biology, neurology, clinical medicine and pharmacy. 410 0$aAdvances in Experimental Medicine and Biology,$x2214-8019 ;$v1264 606 $aMedicine$xResearch 606 $aBiology$xResearch 606 $aNeurosciences 606 $aBiomedical Research 606 $aNeuroscience 615 0$aMedicine$xResearch. 615 0$aBiology$xResearch. 615 0$aNeurosciences. 615 14$aBiomedical Research. 615 24$aNeuroscience. 676 $a615.7827 702 $aMurillo-Rodri?guez$b Eric 702 $aPandi-Perumal$b S. R. 702 $aMonti$b Jaime M. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910484969603321 996 $aCannabinoids and Neuropsychiatric Disorders$94314349 997 $aUNINA